0000950170-24-009096.txt : 20240130 0000950170-24-009096.hdr.sgml : 20240130 20240130211004 ACCESSION NUMBER: 0000950170-24-009096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240126 FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tourangeau Greg CENTRAL INDEX KEY: 0001916566 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38978 FILM NUMBER: 24580392 MAIL ADDRESS: STREET 1: C/O FULCRUM THERAPEUTICS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 ownership.xml 4 X0508 4 2024-01-26 0001680581 Fulcrum Therapeutics, Inc. FULC 0001916566 Tourangeau Greg C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 false true false false Vice President, Finance false Stock Option (right to buy) 6.95 2024-01-26 4 A false 83820 0.00 A 2034-01-25 Common Stock 83820 83820 D Stock Option (right to buy) 6.95 2024-01-26 4 A false 10000 0.00 A 2034-01-25 Common Stock 10000 10000 D This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date. This option was granted on January 26, 2024 and is scheduled to vest in equal yearly installments over two years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date. /s/ Gregory Tourangeau 2024-01-30